NCT07523490 Investigation on Suicide Risk Factors of Patients With Mood Disorders
| NCT ID | NCT07523490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Anding Hospital |
| Condition | Mood Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-12-31 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-12-31 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the level and distribution of suicide risk and learned suicide ability of patients with mood disorders, investigates the related risk factors of suicide and suicide ability formation of patients with mood disorders from multiple dimensions (biological, psychological, social and clinical perspectives) and clarifies their importance, forms a list of suicide risk factors, and establishes a prediction model of learned suicide ability formation. Upon enrollment, participants will undergo comprehensive assessments including blood and urine sample collection and scale evaluation. The collection of scientific blood and urine is mainly used for the exploration of molecular mechanism of disease occurrence and development, the discovery and verification of biomarkers. Scale evaluation includes: Beck Scale for Suicide Ideation , Columbia Suicide Severity Rating Scale,, Hamilton Depression Rating Scale , Hamilton Anxiety Rating Scale, PHQ-9, GAD-7, Personal and Social Function Scale , Schihan Disability Scale , Emotional Adjustment Difficulty Scale , Acquired Capability for Suicide Scale, Interpersonal Needs Questionnaire , Ottawa Self-Injury Scale, Chinese version of Stress Perception Scale and Beck Hopelessness Scale . Follow-up was carried out for 3 months, including whether suicide/self-injury occurred, current status, and some baseline questionnaires (such as BSI-CV, GAD-7, PHQ-9, HAMD-17,HAMA, etc.).
Eligibility Criteria
Inclusion Criteria: 1. Age: 16 to 60 years old; 2. seeing a doctor in a psychiatric clinic or a general hospital; 3. Willing to cooperate in this research project; 4. Sign the informed consent form (minors also need to obtain the informed consent signature of the guardian); 5. Meet the diagnostic criteria of ICD-11 mood disorder. Exclusion Criteria: 1. unable to understand the contents of the questionnaire; 2. Serious organic diseases such as cardiovascular disease, brain disease, liver disease and kidney disease, and weak body, which affect the respondents of the questionnaire; 3. Other circumstances that make it impossible or unwilling to cooperate with the completion of the questionnaire.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07523490 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 60 Years, studying Mood Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07523490 currently recruiting?
Yes, NCT07523490 is actively recruiting participants. Contact the research team at 576491743@qq.com for enrollment information.
Where is the NCT07523490 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07523490 clinical trial?
NCT07523490 is sponsored by Tianjin Anding Hospital. The trial plans to enroll 300 participants.